Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.

导出 OA

翻译打印收藏纠错

第一作者： Ran,Yan

第一单位： Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. ranyan@mednet.ucla.edu.;Department of Bioengineering, Henry Samueli School of Engineering, University of California, Los Angeles, CA, USA. ranyan@mednet.ucla.edu.

作者： Ran,Yan ^[1] ; Wakana,Murakami ^[2] ; Shabnam,Mortazavi ^[3] ; Tiffany,Yu ^[3] ; Fang-I,Chu ^[4] ; Stephanie,Lee-Felker ^[3] ; Kyunghyun,Sung ^[5]

作者单位： Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. ranyan@mednet.ucla.edu.;Department of Bioengineering, Henry Samueli School of Engineering, University of California, Los Angeles, CA, USA. ranyan@mednet.ucla.edu. ^[1] Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.;Department of Radiology, Showa University Graduate School of Medicine, Tokyo, Japan. ^[2] Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. ^[3] Department of Radiation Oncology, University of California, Los Angeles, CA, USA. ^[4] Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.;Department of Bioengineering, Henry Samueli School of Engineering, University of California, Los Angeles, CA, USA. ^[5]

关键词 BRCA germline mutation Background parenchymal enhancement Breast cancer Lifetime risk Quantitative background parenchymal enhancement